SCHEMBL8615835

SCHEMBL8615835

CCCCOCCCCCOc1ccc2nc(-c3ccccc3C)cc(C(=O)NC(=N)N)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.48
CA9 Q16790 4/20 0.48
CA12 O43570 3/20 0.48
CA1 P00915 2/20 0.48
PLA2G2A P14555 3/20 0.44
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 5/20 0.44
KMT2A Q03164 5/20 0.44
MAPT P10636 5/20 0.44
LMNA P02545 4/20 0.44
TDP1 Q9NUW8 4/20 0.44
MEN1 O00255 3/20 0.44
ALOX12 P18054 3/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 5/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
HSP90AA1 P07900 1/20 0.44
GAA P10253 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619277 0.97 CA2 (0.47) CA2CA9CA12CA1PLA2G2A
SCHEMBL8615492 0.89 CA2 (0.53) CA2CA9CA12CA1ALDH1A1
SCHEMBL8618211 0.87 CA2 (0.49) CA2CA9CA12CA1PLA2G2A
SCHEMBL8617279 0.87 CA2 (0.50) CA2CA9CA12CA1ALDH1A1
SCHEMBL8617678 0.85 ALDH1A1 (0.46) CA2CA9CA12CA1PLA2G2A
SCHEMBL8616670 0.84 CA9 (0.65) CA2CA9CA12CA1PLA2G2A
SCHEMBL8618938 0.83 CA2 (0.49) CA2CA9CA12CA1ALDH1A1
SCHEMBL8614068 0.82 MEN1 (0.40) ALDH1A1KDM4EKMT2AMAPTLMNA
SCHEMBL8616557 0.82 TACR3 (0.43) CA2CA9CA12CA1PLA2G2A
SCHEMBL8619081 0.82 CA2 (0.56) CA2CA9CA12CA1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed